Companies
Bio-Techne
S&P 500Health Care· USA

TECH

Status-Quo-Player

Bio-Techne

$57.53

+3.54%

Open $55.42·Prev $55.57

as of 13 Apr

STATUS-QUO-PLAYER

Power Core

The moat in one sentence: Bio-Techne's power derives from being the cited standard in biological reagents, where switching suppliers introduces scientific risk that researchers, journals, and regulators are structurally unwilling to accept.

Published1 Apr 2026
UniverseS&P 500
SectorHealth Care

Direction of Movement

Steady Core Recovery, Growth Segments Await Critical Mass

ROC 200

+2.9%

Referenced in 1 other analysis

Financials

Loading...

This page is for informational purposes only and does not constitute investment advice. L17X Research is an independent research service.
TECH — Bio-Techne — Power Mapping Analysis — L17X — L17X